非结核分枝杆菌肺病中胃食管反流病的医疗利用情况和医疗费用：一项基于韩国人群的研究，2009 - 2017年
Healthcare Utilization and Medical Cost of Gastrointestinal Reflux Disease in Non-tuberculous Mycobacterial Pulmonary Disease: A Population-Based Study, South Korea, 2009-2017.
作者信息
Kim Taehee, Yoon Jai Hoon, Yang Bumhee, Ryu Jiin, Yoon Chang Ki, Kim Youlim, Sohn Jang Won, Lee Hyun, Choi Hayoung
机构信息
Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South Korea.
Department of Gastroenterology, Hanyang University Hospital, Seoul, South Korea.
出版信息
Front Med (Lausanne). 2022 Apr 18;9:793453. doi: 10.3389/fmed.2022.793453. eCollection 2022.
Gastroesophageal reflux disease (GERD) is a common non-respiratory comorbidity in patients with non-tuberculous mycobacterial pulmonary disease (NTM-PD). However, little is known about the association between GERD and healthcare utilization and medical costs of NTM-PD. Thus, we evaluated this association using the Health Insurance Review and Assessment Service National Patient Sample. NTM-PD patients with GERD had significantly higher healthcare use and spent a higher total on medical costs (5,098 vs. 2,675 USD/person/year) than those without GERD ( <0.001 for all). Therefore, an appropriate management of GERD in NTM-PD patients can be an important factor to reduce the disease burden.
胃食管反流病（GERD）是非结核分枝杆菌肺病（NTM-PD）患者中常见的非呼吸系统合并症。然而，关于GERD与NTM-PD的医疗服务利用和医疗费用之间的关联，我们知之甚少。因此，我们使用健康保险审查与评估服务国家患者样本评估了这种关联。与无GERD的NTM-PD患者相比，有GERD的NTM-PD患者的医疗服务使用显著更高，医疗费用总额也更高（5098美元/人/年对2675美元/人/年，所有比较均P<0.001）。因此，对NTM-PD患者的GERD进行适当管理可能是减轻疾病负担的一个重要因素。
Zotero 插件